Similar articles

• Epidemiology of hepatitis C virus in Japan: role in chronic liver disease and hepatocellular carcinoma.

  Yano M, Yatsuhashi H, Inoue O, Koga M. Yano M, et al. J Gastroenterol Hepatol. 1991;6 Suppl 1:31-5. doi: 10.1111/j.1440-1746.1991.tb01165.x. J Gastroenterol Hepatol. 1991. PMID: 1661193 Review. No abstract available.
• Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma.

  Colombo M, Rumi MG, Donato MF, Tommasini MA, Del Ninno E, Ronchi G, Kuo G, Houghton M. Colombo M, et al. Dig Dis Sci. 1991 Aug;36(8):1130-3. doi: 10.1007/BF01297459. Dig Dis Sci. 1991. PMID: 1650689
• Hepatitis C virus infection in cirrhosis and primary hepatocellular carcinoma in Senegal.

  Coursaget P, Leboulleux D, Le Cann P, Bao O, Coll-Seck AM. Coursaget P, et al. Trans R Soc Trop Med Hyg. 1992 Sep-Oct;86(5):552-3. doi: 10.1016/0035-9203(92)90107-n. Trans R Soc Trop Med Hyg. 1992. PMID: 1282278 No abstract available.
• Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease.

  Kato N, Yokosuka O, Hosoda K, Ito Y, Ohto M, Omata M. Kato N, et al. Hepatology. 1993 Jul;18(1):16-20. Hepatology. 1993. PMID: 8392026
• The hepatitis C virus and its relationship to the clinical spectrum of NANB hepatitis.

  Alter HJ. Alter HJ. J Gastroenterol Hepatol. 1990;5 Suppl 1:78-94. doi: 10.1111/j.1440-1746.1990.tb01783.x. J Gastroenterol Hepatol. 1990. PMID: 1966485 Review. No abstract available.